Arcturus Therapeutics Holdings Inc
Biotechnology
Healthcare
ARCT
27.13 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
21.10
52 week high
25.48
high
21.26
52 week low
0.00
low
20.18
growth
-1.70 %
previous Close
21.03
P/E ratio
market cap
470 M
div yield
0
usd
Jun 2025
qoq
revenue
28.30 M
-3.68 %
net incoming
-9.18 M
34.78 %
eps
0.00 %
34.62 %
eps surprise
-110.59 %
net profit margin
-32.44 %
15.00 %
operating incoming
-11.62 M
30.96 %
net change in cash
-20.48 M
-2.00 %
cash on hand
196 M
-9.44 %
cost of revenue
0.00 %
top top